Journal article icon

Journal article

STRIKE-HBV: establishing an HBV screening programme in Kilifi, Kenya—challenges, successes and lessons learnt

Abstract:
OBJECTIVES: Chronic hepatitis B infection affects 65 million people in the WHO African Region, but only 4.2% of these are diagnosed and 0.2% on treatment. Here, we present a short report describing establishment of a hepatitis B virus (HBV) programme in Kenya. We share experiences, successes and challenges to support development of future programmes. METHODS: From March 2023, we began the 'STRIKE-HBV' Study to identify people living with HBV (PLWHB) in Kilifi, Kenya. We employed local staff and provided education and training. Individuals were identified through three routes: (1) we offered free-of-charge HBV testing for all non-pregnant adults attending Kilifi Country Hospital (KCH) outpatient department; (2) we invited PLWHB to reattend for review; and (3) we invited close contacts of PLWHB for screening and vaccination if HBV was negative. All those seropositive for HBV were offered a comprehensive liver health assessment. RESULTS: We have established a framework for HBV screening, assessment and linkage to care in Kilifi. Between March 2023 and March 2024, we collected data for 80 PLWHB, comprising (1) screening of 1862 people of whom 30 were seropositive, (2) enrolment of 38 people known to be living with HBV and (3) testing of 97 close contacts of PLWHB, of whom 12 were positive. Among a limited subset with elastography data, we identified 9 of 59 as having significant fibrosis, and a further 6 people had laboratory aspartate transaminase (AST) to platelet ratio index (APRI) scores in keeping with fibrosis. We encountered challenges including procurement delays for hepatitis B surface antigen testing kits and HBV vaccinations, and issues accessing liver elastography. CONCLUSIONS: HBV screening was well received by the Kilifi population, has identified people at risk of liver disease progression and is improving linkage to care and vaccination at KCH. Future HBV programmes in WHO Africa can build on this experience as we work to develop accessible, affordable and acceptable care pathways
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1136/sextrans-2024-056163

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-6088-4704
More by this author
Role:
Author
ORCID:
0000-0002-1799-8503
More by this author
Role:
Author
ORCID:
0000-0003-3039-5544


More from this funder
Funder identifier:
10.13039/501100000769
Grant:
0012112
More from this funder
Funder identifier:
10.13039/100010269
Grant:
110110/Z/15/Z


Publisher:
BMJ Publishing Group
Journal:
Sexually Transmitted Infections More from this journal
Volume:
100
Issue:
5
Pages:
325-328
Publication date:
2024-05-24
Acceptance date:
2024-05-08
DOI:
EISSN:
1472-3263
ISSN:
1368-4973


Language:
English
Keywords:
Pubs id:
2001671
Local pid:
pubs:2001671
Source identifiers:
W4398765428
Deposit date:
2026-06-11
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP